 | • レポートコード：D0GIR-02933 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、てんかんの世界市場を広く調査・分析し、今後の市場展望をまとめております。てんかんの種類別市場規模（部分発作、局所発作、全身発作、ミオクローヌスミス、ネガティブミオクローヌス、まぶたミオクローヌス、笑い、その他）、用途別市場規模（病院、神経科センター、在宅医療環境、外来手術センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：LivaNova、NeuroPace、GlaxoSmithKline PLC、Johnson & Johnson Services、Medtronic PLC (Ireland)、Eisai、GW Pharmaceuticals、UCB SA、Pfizer、Novartis AG、Takeda、Abbott Laboratories、Bausch Health、Sanofi、Sunovion Pharmaceuticals ・地域別グローバル市場分析 2015年-2020年 ・てんかんの北米市場（アメリカ、カナダ、メキシコ） ・てんかんのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・てんかんのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・てんかんの南米市場（ブラジル、アルゼンチン） ・てんかんの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：部分発作、局所発作、全身発作、ミオクローヌスミス、ネガティブミオクローヌス、まぶたミオクローヌス、笑い、その他 ・用途別分析：病院、神経科センター、在宅医療環境、外来手術センター、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Epilepsy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Epilepsy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Epilepsy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Epilepsy market has been segmented into:
Partial/focal Seizure
Generalized Seizure
Myoclonus Misses
Negative Myoclonus
Eyelid Myoclonus
Laughter
Others
By Application, Epilepsy has been segmented into:
Hospitals
Neurology Centers
Home Care Settings
Ambulatory Surgical Centers
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Epilepsy market presented in the report. This section sheds light on the sales growth of different regional and country-level Epilepsy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Epilepsy market.
The report offers in-depth assessment of the growth and other aspects of the Epilepsy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Epilepsy Market Share Analysis
Epilepsy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Epilepsy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Epilepsy sales, revenue and market share for each player covered in this report.
The major players covered in Epilepsy are:
LivaNova
NeuroPace
GlaxoSmithKline PLC
Johnson & Johnson Services
Medtronic PLC (Ireland)
Eisai
GW Pharmaceuticals
UCB SA
Pfizer
Novartis AG
Takeda
Abbott Laboratories
Bausch Health
Sanofi
Sunovion Pharmaceuticals
Among other players domestic and global, Epilepsy market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Epilepsy Market Overview
1.1 Product Overview and Scope of Epilepsy
1.2 Classification of Epilepsy by Type
1.2.1 Global Epilepsy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Epilepsy Revenue Market Share by Type in 2019
1.2.3 Partial/focal Seizure
1.2.4 Generalized Seizure
1.2.5 Myoclonus Misses
1.2.6 Negative Myoclonus
1.2.7 Eyelid Myoclonus
1.2.8 Laughter
1.2.9 Others
1.3 Global Epilepsy Market by Application
1.3.1 Overview: Global Epilepsy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Neurology Centers
1.3.4 Home Care Settings
1.3.5 Ambulatory Surgical Centers
1.3.6 Others
1.4 Global Epilepsy Market by Regions
1.4.1 Global Epilepsy Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Epilepsy (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Epilepsy Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Epilepsy Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Epilepsy Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Epilepsy Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Epilepsy Status and Prospect (2015-2025)
2 Company Profiles
2.1 LivaNova
2.1.1 LivaNova Details
2.1.2 LivaNova Major Business
2.1.3 LivaNova SWOT Analysis
2.1.4 LivaNova Product and Services
2.1.5 LivaNova Epilepsy Revenue, Gross Margin and Market Share (2018-2019)
2.2 NeuroPace
2.2.1 NeuroPace Details
2.2.2 NeuroPace Major Business
2.2.3 NeuroPace SWOT Analysis
2.2.4 NeuroPace Product and Services
2.2.5 NeuroPace Epilepsy Revenue, Gross Margin and Market Share (2018-2019)
2.3 GlaxoSmithKline PLC
2.3.1 GlaxoSmithKline PLC Details
2.3.2 GlaxoSmithKline PLC Major Business
2.3.3 GlaxoSmithKline PLC SWOT Analysis
2.3.4 GlaxoSmithKline PLC Product and Services
2.3.5 GlaxoSmithKline PLC Epilepsy Revenue, Gross Margin and Market Share (2018-2019)
2.4 Johnson & Johnson Services
2.4.1 Johnson & Johnson Services Details
2.4.2 Johnson & Johnson Services Major Business
2.4.3 Johnson & Johnson Services SWOT Analysis
2.4.4 Johnson & Johnson Services Product and Services
2.4.5 Johnson & Johnson Services Epilepsy Revenue, Gross Margin and Market Share (2018-2019)
2.5 Medtronic PLC (Ireland)
2.5.1 Medtronic PLC (Ireland) Details
2.5.2 Medtronic PLC (Ireland) Major Business
2.5.3 Medtronic PLC (Ireland) SWOT Analysis
2.5.4 Medtronic PLC (Ireland) Product and Services
2.5.5 Medtronic PLC (Ireland) Epilepsy Revenue, Gross Margin and Market Share (2018-2019)
2.6 Eisai
2.6.1 Eisai Details
2.6.2 Eisai Major Business
2.6.3 Eisai Product and Services
2.6.4 Eisai Epilepsy Revenue, Gross Margin and Market Share (2018-2019)
2.7 GW Pharmaceuticals
2.7.1 GW Pharmaceuticals Details
2.7.2 GW Pharmaceuticals Major Business
2.7.3 GW Pharmaceuticals Product and Services
2.7.4 GW Pharmaceuticals Epilepsy Revenue, Gross Margin and Market Share (2018-2019)
2.8 UCB SA
2.8.1 UCB SA Details
2.8.2 UCB SA Major Business
2.8.3 UCB SA Product and Services
2.8.4 UCB SA Epilepsy Revenue, Gross Margin and Market Share (2018-2019)
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Product and Services
2.9.4 Pfizer Epilepsy Revenue, Gross Margin and Market Share (2018-2019)
2.10 Novartis AG
2.10.1 Novartis AG Details
2.10.2 Novartis AG Major Business
2.10.3 Novartis AG Product and Services
2.10.4 Novartis AG Epilepsy Revenue, Gross Margin and Market Share (2018-2019)
2.11 Takeda
2.11.1 Takeda Details
2.11.2 Takeda Major Business
2.11.3 Takeda Product and Services
2.11.4 Takeda Epilepsy Revenue, Gross Margin and Market Share (2018-2019)
2.12 Abbott Laboratories
2.12.1 Abbott Laboratories Details
2.12.2 Abbott Laboratories Major Business
2.12.3 Abbott Laboratories Product and Services
2.12.4 Abbott Laboratories Epilepsy Revenue, Gross Margin and Market Share (2018-2019)
2.13 Bausch Health
2.13.1 Bausch Health Details
2.13.2 Bausch Health Major Business
2.13.3 Bausch Health Product and Services
2.13.4 Bausch Health Epilepsy Revenue, Gross Margin and Market Share (2018-2019)
2.14 Sanofi
2.14.1 Sanofi Details
2.14.2 Sanofi Major Business
2.14.3 Sanofi Product and Services
2.14.4 Sanofi Epilepsy Revenue, Gross Margin and Market Share (2018-2019)
2.15 Sunovion Pharmaceuticals
2.15.1 Sunovion Pharmaceuticals Details
2.15.2 Sunovion Pharmaceuticals Major Business
2.15.3 Sunovion Pharmaceuticals Product and Services
2.15.4 Sunovion Pharmaceuticals Epilepsy Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Epilepsy Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Epilepsy Players Market Share
3.2.2 Top 10 Epilepsy Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Epilepsy Revenue and Market Share by Regions
4.2 North America Epilepsy Revenue and Growth Rate (2015-2020)
4.3 Europe Epilepsy Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Epilepsy Revenue and Growth Rate (2015-2020)
4.5 South America Epilepsy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Epilepsy Revenue and Growth Rate (2015-2020)
5 North America Epilepsy Revenue by Countries
5.1 North America Epilepsy Revenue by Countries (2015-2020)
5.2 USA Epilepsy Revenue and Growth Rate (2015-2020)
5.3 Canada Epilepsy Revenue and Growth Rate (2015-2020)
5.4 Mexico Epilepsy Revenue and Growth Rate (2015-2020)
6 Europe Epilepsy Revenue by Countries
6.1 Europe Epilepsy Revenue by Countries (2015-2020)
6.2 Germany Epilepsy Revenue and Growth Rate (2015-2020)
6.3 UK Epilepsy Revenue and Growth Rate (2015-2020)
6.4 France Epilepsy Revenue and Growth Rate (2015-2020)
6.5 Russia Epilepsy Revenue and Growth Rate (2015-2020)
6.6 Italy Epilepsy Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Epilepsy Revenue by Countries
7.1 Asia-Pacific Epilepsy Revenue by Countries (2015-2020)
7.2 China Epilepsy Revenue and Growth Rate (2015-2020)
7.3 Japan Epilepsy Revenue and Growth Rate (2015-2020)
7.4 Korea Epilepsy Revenue and Growth Rate (2015-2020)
7.5 India Epilepsy Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Epilepsy Revenue and Growth Rate (2015-2020)
8 South America Epilepsy Revenue by Countries
8.1 South America Epilepsy Revenue by Countries (2015-2020)
8.2 Brazil Epilepsy Revenue and Growth Rate (2015-2020)
8.3 Argentina Epilepsy Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Epilepsy by Countries
9.1 Middle East & Africa Epilepsy Revenue by Countries (2015-2020)
9.2 Saudi Arabia Epilepsy Revenue and Growth Rate (2015-2020)
9.3 UAE Epilepsy Revenue and Growth Rate (2015-2020)
9.4 Egypt Epilepsy Revenue and Growth Rate (2015-2020)
9.5 South Africa Epilepsy Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Epilepsy Revenue and Market Share by Type (2015-2020)
10.2 Global Epilepsy Market Forecast by Type (2019-2024)
10.3 Partial/focal Seizure Revenue Growth Rate (2015-2025)
10.4 Generalized Seizure Revenue Growth Rate (2015-2025)
10.5 Myoclonus Misses Revenue Growth Rate (2015-2025)
10.6 Negative Myoclonus Revenue Growth Rate (2015-2025)
10.7 Eyelid Myoclonus Revenue Growth Rate (2015-2025)
10.8 Laughter Revenue Growth Rate (2015-2025)
10.9 Others Revenue Growth Rate (2015-2025)
11 Global Epilepsy Market Segment by Application
11.1 Global Epilepsy Revenue Market Share by Application (2015-2020)
11.2 Epilepsy Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Neurology Centers Revenue Growth (2015-2020)
11.5 Home Care Settings Revenue Growth (2015-2020)
11.6 Ambulatory Surgical Centers Revenue Growth (2015-2020)
11.7 Others Revenue Growth (2015-2020)
12 Global Epilepsy Market Size Forecast (2021-2025)
12.1 Global Epilepsy Market Size Forecast (2021-2025)
12.2 Global Epilepsy Market Forecast by Regions (2021-2025)
12.3 North America Epilepsy Revenue Market Forecast (2021-2025)
12.4 Europe Epilepsy Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Epilepsy Revenue Market Forecast (2021-2025)
12.6 South America Epilepsy Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Epilepsy Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Epilepsy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Epilepsy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Epilepsy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Epilepsy Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Epilepsy Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. LivaNova Corporate Information, Location and Competitors
Table 7. LivaNova Epilepsy Major Business
Table 8. LivaNova Epilepsy Total Revenue (USD Million) (2017-2018)
Table 9. LivaNova SWOT Analysis
Table 10. LivaNova Epilepsy Product and Solutions
Table 11. LivaNova Epilepsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. NeuroPace Corporate Information, Location and Competitors
Table 13. NeuroPace Epilepsy Major Business
Table 14. NeuroPace Epilepsy Total Revenue (USD Million) (2018-2019)
Table 15. NeuroPace SWOT Analysis
Table 16. NeuroPace Epilepsy Product and Solutions
Table 17. NeuroPace Epilepsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. GlaxoSmithKline PLC Corporate Information, Location and Competitors
Table 19. GlaxoSmithKline PLC Epilepsy Major Business
Table 20. GlaxoSmithKline PLC Epilepsy Total Revenue (USD Million) (2017-2018)
Table 21. GlaxoSmithKline PLC SWOT Analysis
Table 22. GlaxoSmithKline PLC Epilepsy Product and Solutions
Table 23. GlaxoSmithKline PLC Epilepsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Johnson & Johnson Services Corporate Information, Location and Competitors
Table 25. Johnson & Johnson Services Epilepsy Major Business
Table 26. Johnson & Johnson Services Epilepsy Total Revenue (USD Million) (2017-2018)
Table 27. Johnson & Johnson Services SWOT Analysis
Table 28. Johnson & Johnson Services Epilepsy Product and Solutions
Table 29. Johnson & Johnson Services Epilepsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Medtronic PLC (Ireland) Corporate Information, Location and Competitors
Table 31. Medtronic PLC (Ireland) Epilepsy Major Business
Table 32. Medtronic PLC (Ireland) Epilepsy Total Revenue (USD Million) (2017-2018)
Table 33. Medtronic PLC (Ireland) SWOT Analysis
Table 34. Medtronic PLC (Ireland) Epilepsy Product and Solutions
Table 35. Medtronic PLC (Ireland) Epilepsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Eisai Corporate Information, Location and Competitors
Table 37. Eisai Epilepsy Major Business
Table 38. Eisai Epilepsy Total Revenue (USD Million) (2017-2018)
Table 39. Eisai SWOT Analysis
Table 40. Eisai Epilepsy Product and Solutions
Table 41. Eisai Epilepsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. GW Pharmaceuticals Corporate Information, Location and Competitors
Table 43. GW Pharmaceuticals Epilepsy Major Business
Table 44. GW Pharmaceuticals Epilepsy Total Revenue (USD Million) (2017-2018)
Table 45. GW Pharmaceuticals SWOT Analysis
Table 46. GW Pharmaceuticals Epilepsy Product and Solutions
Table 47. GW Pharmaceuticals Epilepsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. UCB SA Corporate Information, Location and Competitors
Table 49. UCB SA Epilepsy Major Business
Table 50. UCB SA Epilepsy Total Revenue (USD Million) (2017-2018)
Table 51. UCB SA SWOT Analysis
Table 52. UCB SA Epilepsy Product and Solutions
Table 53. UCB SA Epilepsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Pfizer Corporate Information, Location and Competitors
Table 55. Pfizer Epilepsy Major Business
Table 56. Pfizer Epilepsy Total Revenue (USD Million) (2017-2018)
Table 57. Pfizer SWOT Analysis
Table 58. Pfizer Epilepsy Product and Solutions
Table 59. Pfizer Epilepsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Novartis AG Corporate Information, Location and Competitors
Table 61. Novartis AG Epilepsy Major Business
Table 62. Novartis AG Epilepsy Total Revenue (USD Million) (2017-2018)
Table 63. Novartis AG SWOT Analysis
Table 64. Novartis AG Epilepsy Product and Solutions
Table 65. Novartis AG Epilepsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Takeda Corporate Information, Location and Competitors
Table 67. Takeda Epilepsy Major Business
Table 68. Takeda Epilepsy Total Revenue (USD Million) (2017-2018)
Table 69. Takeda SWOT Analysis
Table 70. Takeda Epilepsy Product and Solutions
Table 71. Takeda Epilepsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Abbott Laboratories Corporate Information, Location and Competitors
Table 73. Abbott Laboratories Epilepsy Major Business
Table 74. Abbott Laboratories Epilepsy Total Revenue (USD Million) (2017-2018)
Table 75. Abbott Laboratories SWOT Analysis
Table 76. Abbott Laboratories Epilepsy Product and Solutions
Table 77. Abbott Laboratories Epilepsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Bausch Health Corporate Information, Location and Competitors
Table 79. Bausch Health Epilepsy Major Business
Table 80. Bausch Health Epilepsy Total Revenue (USD Million) (2017-2018)
Table 81. Bausch Health SWOT Analysis
Table 82. Bausch Health Epilepsy Product and Solutions
Table 83. Bausch Health Epilepsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Sanofi Corporate Information, Location and Competitors
Table 85. Sanofi Epilepsy Major Business
Table 86. Sanofi Epilepsy Total Revenue (USD Million) (2017-2018)
Table 87. Sanofi SWOT Analysis
Table 88. Sanofi Epilepsy Product and Solutions
Table 89. Sanofi Epilepsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Sunovion Pharmaceuticals Corporate Information, Location and Competitors
Table 91. Sunovion Pharmaceuticals Epilepsy Major Business
Table 92. Sunovion Pharmaceuticals Epilepsy Total Revenue (USD Million) (2017-2018)
Table 93. Sunovion Pharmaceuticals SWOT Analysis
Table 94. Sunovion Pharmaceuticals Epilepsy Product and Solutions
Table 95. Sunovion Pharmaceuticals Epilepsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Global Epilepsy Revenue (Million USD) by Players (2015-2020)
Table 97. Global Epilepsy Revenue Share by Players (2015-2020)
Table 98. Global Epilepsy Revenue (Million USD) by Regions (2015-2020)
Table 99. Global Epilepsy Revenue Market Share by Regions (2015-2020)
Table 100. North America Epilepsy Revenue by Countries (2015-2020)
Table 101. North America Epilepsy Revenue Market Share by Countries (2015-2020)
Table 102. Europe Epilepsy Revenue (Million USD) by Countries (2015-2020)
Table 103. Asia-Pacific Epilepsy Revenue (Million USD) by Countries (2015-2020)
Table 104. South America Epilepsy Revenue by Countries (2015-2020)
Table 105. South America Epilepsy Revenue Market Share by Countries (2015-2020)
Table 106. Middle East and Africa Epilepsy Revenue (Million USD) by Countries (2015-2020)
Table 107. Middle East and Africa Epilepsy Revenue Market Share by Countries (2015-2020)
Table 108. Global Epilepsy Revenue (Million USD) by Type (2015-2020)
Table 109. Global Epilepsy Revenue Share by Type (2015-2020)
Table 110. Global Epilepsy Revenue Forecast by Type (2021-2025)
Table 111. Global Epilepsy Revenue by Application (2015-2020)
Table 112. Global Epilepsy Revenue Share by Application (2015-2020)
Table 113. Global Epilepsy Revenue Forecast by Application (2021-2025)
Table 114. Global Epilepsy Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Epilepsy Picture
Figure 2. Global Epilepsy Revenue Market Share by Type in 2019
Figure 3. Partial/focal Seizure Picture
Figure 4. Generalized Seizure Picture
Figure 5. Myoclonus Misses Picture
Figure 6. Negative Myoclonus Picture
Figure 7. Eyelid Myoclonus Picture
Figure 8. Laughter Picture
Figure 9. Others Picture
Figure 10. Epilepsy Revenue Market Share by Application in 2019
Figure 11. Hospitals Picture
Figure 12. Neurology Centers Picture
Figure 13. Home Care Settings Picture
Figure 14. Ambulatory Surgical Centers Picture
Figure 15. Others Picture
Figure 16. Global Epilepsy Revenue (USD Million) and Growth Rate (2015-2025)
Figure 17. North America Epilepsy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Europe Epilepsy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Asia-Pacific Epilepsy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. South America Epilepsy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Middle East and Africa Epilepsy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Epilepsy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. Global Epilepsy Revenue Share by Players in 2019
Figure 24. Global Top 5 Players Epilepsy Revenue Market Share in 2019
Figure 25. Global Top 10 Players Epilepsy Revenue Market Share in 2019
Figure 26. Key Players Market Share Trend
Figure 27. Global Epilepsy Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 28. Global Epilepsy Revenue Market Share by Regions (2015-2020)
Figure 29. Global Epilepsy Revenue Market Share by Regions in 2018
Figure 30. North America Epilepsy Revenue and Growth Rate (2015-2020)
Figure 31. Europe Epilepsy Revenue and Growth Rate (2015-2020)
Figure 32. Asia-Pacific Epilepsy Revenue and Growth Rate (2015-2020)
Figure 33. South America Epilepsy Revenue and Growth Rate (2015-2020)
Figure 34. Middle East and Africa Epilepsy Revenue and Growth Rate (2015-2020)
Figure 35. North America Epilepsy Revenue Market Share by Countries (2015-2020)
Figure 36. North America Epilepsy Revenue Market Share by Countries in 2019
Figure 37. USA Epilepsy Revenue and Growth Rate (2015-2020)
Figure 38. Canada Epilepsy Revenue and Growth Rate (2015-2020)
Figure 39. Mexico Epilepsy Revenue and Growth Rate (2015-2020)
Figure 40. Europe Epilepsy Revenue Market Share by Countries (2015-2020)
Figure 41. Europe Epilepsy Revenue Market Share by Countries in 2019
Figure 42. Germany Epilepsy Revenue and Growth Rate (2015-2020)
Figure 43. UK Epilepsy Revenue and Growth Rate (2015-2020)
Figure 44. France Epilepsy Revenue and Growth Rate (2015-2020)
Figure 45. Russia Epilepsy Revenue and Growth Rate (2015-2020)
Figure 46. Italy Epilepsy Revenue and Growth Rate (2015-2020)
Figure 47. Asia-Pacific Epilepsy Revenue Market Share by Countries (2015-2020)
Figure 48. Asia-Pacific Epilepsy Revenue Market Share by Countries in 2019
Figure 49. China Epilepsy Revenue and Growth Rate (2015-2020)
Figure 50. Japan Epilepsy Revenue and Growth Rate (2015-2020)
Figure 51. Korea Epilepsy Revenue and Growth Rate (2015-2020)
Figure 52. India Epilepsy Revenue and Growth Rate (2015-2020)
Figure 53. Southeast Asia Epilepsy Revenue and Growth Rate (2015-2020)
Figure 54. South America Epilepsy Revenue Market Share by Countries (2015-2020)
Figure 55. South America Epilepsy Revenue Market Share by Countries in 2019
Figure 56. Brazil Epilepsy Revenue and Growth Rate (2015-2020)
Figure 57. Argentina Epilepsy Revenue and Growth Rate (2015-2020)
Figure 58. Middle East and Africa Epilepsy Revenue Market Share by Countries (2015-2020)
Figure 59. Middle East and Africa Epilepsy Revenue Market Share by Countries in 2019
Figure 60. Saudi Arabia Epilepsy Revenue and Growth Rate (2015-2020)
Figure 61. UAE Epilepsy Revenue and Growth Rate (2015-2020)
Figure 62. Egypt Epilepsy Revenue and Growth Rate (2015-2020)
Figure 63. South Africa Epilepsy Revenue and Growth Rate (2015-2020)
Figure 64. Global Epilepsy Revenue Share by Type (2015-2020)
Figure 65. Global Epilepsy Revenue Share by Type in 2019
Figure 66. Global Epilepsy Market Share Forecast by Type (2021-2025)
Figure 67. Global Partial/focal Seizure Revenue Growth Rate (2015-2020)
Figure 68. Global Generalized Seizure Revenue Growth Rate (2015-2020)
Figure 69. Global Myoclonus Misses Revenue Growth Rate (2015-2020)
Figure 70. Global Negative Myoclonus Revenue Growth Rate (2015-2020)
Figure 71. Global Eyelid Myoclonus Revenue Growth Rate (2015-2020)
Figure 72. Global Laughter Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Epilepsy Revenue Share by Application (2015-2020)
Figure 75. Global Epilepsy Revenue Share by Application in 2019
Figure 76. Global Epilepsy Market Share Forecast by Application (2021-2025)
Figure 77. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 78. Global Neurology Centers Revenue Growth Rate (2015-2020)
Figure 79. Global Home Care Settings Revenue Growth Rate (2015-2020)
Figure 80. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 81. Global Others Revenue Growth Rate (2015-2020)
Figure 82. Global Epilepsy Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 83. Global Epilepsy Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 84. Global Epilepsy Revenue Market Share Forecast by Regions (2021-2025)
Figure 85. North America Epilepsy Revenue Market Forecast (2021-2025)
Figure 86. Europe Epilepsy Revenue Market Forecast (2021-2025)
Figure 87. Asia-Pacific Epilepsy Revenue Market Forecast (2021-2025)
Figure 88. South America Epilepsy Revenue Market Forecast (2021-2025)
Figure 89. Middle East and Africa Epilepsy Revenue Market Forecast (2021-2025)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
小児てんかん治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Pediatric Epilepsy Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pediatric Epi…- てんかん治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Epilepsy Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.4% in the forecast period of 2020 to 2025 and will expected to reach USD 1997.1 million by 2025, from USD 1892.4 million in 2019. The Epilepsy Drug market r…
- てんかん診断・治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Epilepsy Diagnosis & Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 14.4% in the forecast period of 2020 to 2025 and will expected to reach USD 13710 million by 2025, from USD 8003.9 million in 2019. The Epile…
- 発作治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Seizure Treatments market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Seizure Treatments market …
- 大発作 の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Grand Mal Seizure market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.3% in the forecast period of 2020 to 2025 and will expected to reach USD 22400 million by 2025, from USD 20470 million in 2019. The Grand Mal Seizure ma…